0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 67 results.
The present Competitive Intelligence Report about alpha1-proteinase inhibitors (alpha1-PI), alpha1-antitrypsin (AAT) and elastase inhibitors provides...
Catalog:
La Merie Publishing
July 2014
Price: USD 272.00
The Competitive Intelligence report about sphingosine-1-phosphate (S1P) receptor modulators provides a competitor analysis of approved or novel S1P...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of...
Catalog:
La Merie Publishing
September 2014
Price: USD 254.00
The three Pim kinases are a small family of serine/threonine kinases regulating several signaling pathways that are fundamental to cancer development...
Catalog:
La Merie Publishing
September 2013
Price: USD 199.00
Wnt proteins are secreted glycoproteins acting as short or long range signaling molecules. To trigger a cellular response and to activate...
Catalog:
La Merie Publishing
September 2013
Price: USD 132.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
Catalog:
La Merie Publishing
June 2019
Price: USD 900.00
Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast...
Catalog:
Rockville Research
April 2019
Price: USD 1,100.00
The Competitive Intelligence report about inhibitors of interleukin-4 (IL-4) and/or IL-13 and antagonists of the IL-4 or IL-13 receptor provides a...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
The Competitive Intelligence report about Interleukin-23 (IL-23) and IL-12/23 antagonists provides a competitor analysis of approved or being...
Catalog:
La Merie Publishing
September 2015
Price: USD 115.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
Global oncology market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and...
Catalog:
NAVADHI
May 2019
Price: USD 2,000.00
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic...
Catalog:
La Merie Publishing
March 2015
Price: USD 140.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital...
Catalog:
iGATE
July 2017
Price: USD 1,890.00
Asia Pacific transcriptomics market will grow by 13.1% annually with a total addressable market cap of $ 29,787.1 million over 2022-2031, driven by...
Catalog:
Grace Market Data
October 2022
Price: USD 2,580.00
